We are live on ! Find out more
CWM

CIBC World Markets Portfolio holdings

AUM $20.8B
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$4.36B
Cap. Flow
-$3.8B
Cap. Flow %
-29.89%
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$211M
2
CCI icon
Crown Castle
CCI
+$52.2M
3
TSLA icon
Tesla
TSLA
+$46.6M
4
XP icon
XP
XP
+$25.2M
5
EA
Electronic Arts
EA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 31.12%
2 Financials 11.86%
3 Consumer Discretionary 10.19%
4 Communication Services 9.97%
5 Healthcare 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWI
1401
DELISTED
SolarWinds Corporation Common Stock
SWI
$226K ﹤0.01%
+12,249
New +$205K
GSAT icon
1402
Globalstar
GSAT
$10.8B
$225K ﹤0.01%
10,792
+6,240
+137% +$151K
SCS
1403
DELISTED
Steelcase
SCS
$225K ﹤0.01%
+20,538
New +$237K
APOG icon
1404
Apogee Enterprises
APOG
$908M
$225K ﹤0.01%
+4,852
New +$248K
DXPE icon
1405
DXP Enterprises
DXPE
$2.98B
$224K ﹤0.01%
+2,729
New +$252K
AAPL icon
1406
CALL
Apple
AAPL
$4.57T
$224K ﹤0.01%
+1,010
New +$234K
JAMF
1407
DELISTED
Jamf
JAMF
$224K ﹤0.01%
+18,462
New +$265K
DGII icon
1408
Digi International
DGII
$3.1B
$224K ﹤0.01%
+8,059
New +$249K
SNDX icon
1409
Syndax Pharmaceuticals
SNDX
$1.82B
$224K ﹤0.01%
+18,233
New +$257K
VRDN icon
1410
Viridian Therapeutics
VRDN
$2.67B
$223K ﹤0.01%
+16,557
New +$282K
INVA icon
1411
Innoviva
INVA
$1.48B
$223K ﹤0.01%
+12,279
New +$220K
TPC
1412
Tutor Perini Cor
TPC
$5.21B
$223K ﹤0.01%
+9,603
New +$237K
AMSF icon
1413
AMERISAFE
AMSF
$540M
$222K ﹤0.01%
+4,227
New +$214K
MCRI icon
1414
Monarch Casino & Resort
MCRI
$2.23B
$221K ﹤0.01%
+2,846
New +$242K
EYE icon
1415
National Vision
EYE
$1.81B
$221K ﹤0.01%
+17,276
New +$204K
IMVT icon
1416
Immunovant
IMVT
$8.25B
$220K ﹤0.01%
+12,880
New +$269K
BTSG icon
1417
BrightSpring Health Services
BTSG
$12.4B
$220K ﹤0.01%
+12,154
New +$239K
ACT icon
1418
Enact Holdings
ACT
$6.73B
$219K ﹤0.01%
+6,310
New +$211K
NVAX icon
1419
Novavax
NVAX
$1.31B
$219K ﹤0.01%
34,204
+19,778
+137% +$163K
JBI icon
1420
Janus International
JBI
$757M
$219K ﹤0.01%
30,421
+17,144
+129% +$136K
KW
1421
DELISTED
Kennedy-Wilson Holdings
KW
$219K ﹤0.01%
25,232
+14,591
+137% +$133K
FOXF icon
1422
Fox Factory Holding Corp
FOXF
$886M
$219K ﹤0.01%
+9,383
New +$251K
LGF.B
1423
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$219K ﹤0.01%
27,621
+15,972
+137% +$128K
CENX icon
1424
Century Aluminum
CENX
$5.07B
$217K ﹤0.01%
+11,714
New +$225K
OCFC icon
1425
OceanFirst Financial
OCFC
$1.91B
$217K ﹤0.01%
+12,765
New +$227K

Similar funds

CIBC World Markets's Q1 2025 Portfolio in Review

As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.

  • CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
  • CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
  • CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
  • CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
  • CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
  • CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
  • CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.

Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.